Stolinsky D C, Weiner J M, Bateman J R
Oncology. 1980;37(1):62-3. doi: 10.1159/000225404.
9 patients with chronic granulocytic leukemia were treated sequentially with busulfan, 6-mercaptopurine, and trimethylcolchicinic acid methyl ether d-tartrate (TMCA; NSC-36354). Smoothness of control of the disease was similar with busulfan and 6-mercaptopurine, but it was significantly poorer with TMCA. Toxic effects of therapy and median survival were similar to those observed with conventional therapy.
9例慢性粒细胞白血病患者先后接受白消安、6-巯基嘌呤和三甲基秋水仙碱甲基醚d-酒石酸盐（TMCA；NSC-36354）治疗。白消安和6-巯基嘌呤对疾病的控制平稳程度相似，但TMCA的效果明显较差。治疗的毒性作用和中位生存期与传统治疗观察到的情况相似。
